Search Results - jynho+kim

1 Results Sort By:
Arsenic compounds for Hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies
INVENTION NOVELTYJohns Hopkins researchers have developed a novel Hedgehog signaling pathway inhibitor that can be used in the treatment of various types of leukemia.VALUE PROPOSITIONThe Hedgehog (Hh) pathway has been found to be important in a number of cancers. Various Hh inhibitors, specifically Smo antagonists, are in development or have been launched...
Published: 10/3/2024   |   Inventor(s): Jynho Kim, Philip Beachy
Keywords(s): Antagonists/Inhibitors, Cancers, Disease Indication, Non-novel, Predicted Novelty, Single, Small Molecules, Targeted Therapy, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum